One Year Later: Our ‘No-Brainer’ Rigetti Call Doubled. What to Do Now.

One twelvemonth ago, 24/7 Wall St. published a buy-the-dip telephone connected Rigetti Computing (NASDAQ: RGTI). The thesis rested connected Nvidia's pivot into quantum, real-time mistake correction connected the 84-qubit Ankaa-2, the December 2024 motorboat of Ankaa-3 with 99.5% median two-qubit gross fidelity, a $100 cardinal equity raise, and a planned modular 36-qubit strategy built from interconnected 9-qubit chips.

The telephone astir doubled. Here is the study card:

The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks. Get them present FREE.

Most of the thesis pillars played out. Rigetti released Cepheus-1-36Q successful Q2 2025 (the modular chiplet system), deed 99.9% two-qubit gross fidelity astatine 28 nanoseconds connected a prototype, and stacked partnerships with Riverlane, Nvidia, Quanta Computer, and QphoX. Quanta's $35 cardinal backstage placement closed, and CEO Subodh Kulkarni framed the advancement bluntly: "In 2025, we made large advancement crossed fidelity, scale, and strategy architecture." Commercial traction followed, including an $8.4 cardinal C-DAC bid for a 108-qubit strategy and $5.7 cardinal successful Novera acquisition orders.

The banal peaked astatine astir $58.15 earlier retracing. Valuation is the culprit: a $5.8 cardinal marketplace headdress sits connected $7.09 cardinal successful full-year 2025 gross (down from $10.79 cardinal successful 2024) and a $216.21 cardinal nett loss. The price-to-sales ratio is 855. Q4 gross missed statement by 21.68%, and shares fell 18.44% successful the 30 days pursuing the Q4 print. Reddit sentiment whipsawed from euphoria successful precocious October 2025 (scores 61 to 81) to precise bearish by aboriginal December (12 to 18) connected insider-selling narratives.

The bull lawsuit inactive has legs. Rigetti closed 2025 with $589.83 cardinal successful currency and investments, the roadmap targets a 1,000+ qubit strategy by extremity of 2027, and 9 of 12 analysts complaint it Buy oregon better, with a $30.58 target. The carnivore lawsuit is arsenic real: gross shrinking, losses widening, and dilution from 171.9 cardinal to 298.3 cardinal shares. For investors who doubled up, trimming to a house-money presumption is defensible probe guidance. For caller money, the existent 47% drawdown from highs is simply a amended introduction than October 2025, but size it for a 1.83 beta banal that trades connected narrative, not earnings.